• Home
  • Search Results
  • Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.

Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.

Cancer letters (2014-07-19)
Kai Mao, Jianlong Zhang, Chuanchao He, Kang Xu, Jieqiong Liu, Jian Sun, Gang Wu, Cui Tan, Yunjie Zeng, Jie Wang, Zhiyu Xiao

Chronic infection with Hepatitis B virus (HBV) is the major risk factor of Hepatocellular Carcinoma (HCC). This study is to explore the mechanism of sorafenib resistance and find an effective strategy to sensitize HBV-associated HCC to sorafenib. Cytotoxicity to sorafenib was evaluated in HBV-positive/negative HCC cell lines. Expression of miR-193b and myeloid cell leukemia-1 (Mcl-1) protein were assessed by Q-PCR, in situ hybridization and western blot, immunohistochemistry, respectively. A luciferase reporter of Mcl-1 3'-UTR was used for validation as a target of miR-193b. Cell apoptosis was measured by flow cytometry, caspase-3 activity assay and DAPI staining. The IC50 to sorafenib was significantly higher in HBV-positive HCC cells than those without HBV infection. Significant downregulation of miR-193b and a higher level of Mcl-1 were observed in HBV-positive HCC cells and tissues. The activity of Mcl-1 3'-UTR reporter was inhibited by co-transfection with miR-193b mimic. Restoring the expression of miR-193b sensitized HBV-associated HCC cells to sorafenib treatment and facilitated sorafenib-induced apoptosis. Modulation of miRNAs expression might be a potential way to enhance response to sorafenib in HBV-associated HCC.

Product Number
Product Description

Niacinamide, United States Pharmacopeia (USP) Reference Standard
Nicotinamide (Vitamin B3) solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Nicotinamide, ≥98% (HPLC), powder
Nicotinamide, European Pharmacopoeia (EP) Reference Standard
Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material
Nicotinamide, ≥99.5% (HPLC)
Niacinamide, meets USP testing specifications
Nicotinamide, ≥98.5% (HPLC)
Nicotinamide (Niacinamide), analytical standard